These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

279 related items for PubMed ID: 15743808

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Y box-binding protein 1 induces resistance to oncogenic transformation by the phosphatidylinositol 3-kinase pathway.
    Bader AG, Felts KA, Jiang N, Chang HW, Vogt PK.
    Proc Natl Acad Sci U S A; 2003 Oct 14; 100(21):12384-9. PubMed ID: 14530393
    [Abstract] [Full Text] [Related]

  • 3. Phosphorylation by Akt disables the anti-oncogenic activity of YB-1.
    Bader AG, Vogt PK.
    Oncogene; 2008 Feb 14; 27(8):1179-82. PubMed ID: 17704806
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. A role of the kinase mTOR in cellular transformation induced by the oncoproteins P3k and Akt.
    Aoki M, Blazek E, Vogt PK.
    Proc Natl Acad Sci U S A; 2001 Jan 02; 98(1):136-41. PubMed ID: 11134523
    [Abstract] [Full Text] [Related]

  • 6. Proteasomal degradation of the FoxO1 transcriptional regulator in cells transformed by the P3k and Akt oncoproteins.
    Aoki M, Jiang H, Vogt PK.
    Proc Natl Acad Sci U S A; 2004 Sep 14; 101(37):13613-7. PubMed ID: 15342912
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Akt phosphorylates the Y-box binding protein 1 at Ser102 located in the cold shock domain and affects the anchorage-independent growth of breast cancer cells.
    Sutherland BW, Kucab J, Wu J, Lee C, Cheang MC, Yorida E, Turbin D, Dedhar S, Nelson C, Pollak M, Leighton Grimes H, Miller K, Badve S, Huntsman D, Blake-Gilks C, Chen M, Pallen CJ, Dunn SE.
    Oncogene; 2005 Jun 16; 24(26):4281-92. PubMed ID: 15806160
    [Abstract] [Full Text] [Related]

  • 9. The akt kinase: molecular determinants of oncogenicity.
    Aoki M, Batista O, Bellacosa A, Tsichlis P, Vogt PK.
    Proc Natl Acad Sci U S A; 1998 Dec 08; 95(25):14950-5. PubMed ID: 9843996
    [Abstract] [Full Text] [Related]

  • 10. An acidic protein, YBAP1, mediates the release of YB-1 from mRNA and relieves the translational repression activity of YB-1.
    Matsumoto K, Tanaka KJ, Tsujimoto M.
    Mol Cell Biol; 2005 Mar 08; 25(5):1779-92. PubMed ID: 15713634
    [Abstract] [Full Text] [Related]

  • 11. Characterization of the 5'-untranslated region of YB-1 mRNA and autoregulation of translation by YB-1 protein.
    Fukuda T, Ashizuka M, Nakamura T, Shibahara K, Maeda K, Izumi H, Kohno K, Kuwano M, Uchiumi T.
    Nucleic Acids Res; 2004 Mar 08; 32(2):611-22. PubMed ID: 14752049
    [Abstract] [Full Text] [Related]

  • 12. YB-1 autoregulates translation of its own mRNA at or prior to the step of 40S ribosomal subunit joining.
    Skabkina OV, Lyabin DN, Skabkin MA, Ovchinnikov LP.
    Mol Cell Biol; 2005 Apr 08; 25(8):3317-23. PubMed ID: 15798215
    [Abstract] [Full Text] [Related]

  • 13. Oncogenic TLS/ERG and EWS/Fli-1 fusion proteins inhibit RNA splicing mediated by YB-1 protein.
    Chansky HA, Hu M, Hickstein DD, Yang L.
    Cancer Res; 2001 May 01; 61(9):3586-90. PubMed ID: 11325824
    [Abstract] [Full Text] [Related]

  • 14. Akt-mediated YB-1 phosphorylation activates translation of silent mRNA species.
    Evdokimova V, Ruzanov P, Anglesio MS, Sorokin AV, Ovchinnikov LP, Buckley J, Triche TJ, Sonenberg N, Sorensen PH.
    Mol Cell Biol; 2006 Jan 01; 26(1):277-92. PubMed ID: 16354698
    [Abstract] [Full Text] [Related]

  • 15. The mRNA-binding protein YB-1 (p50) prevents association of the eukaryotic initiation factor eIF4G with mRNA and inhibits protein synthesis at the initiation stage.
    Nekrasov MP, Ivshina MP, Chernov KG, Kovrigina EA, Evdokimova VM, Thomas AA, Hershey JW, Ovchinnikov LP.
    J Biol Chem; 2003 Apr 18; 278(16):13936-43. PubMed ID: 12582179
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Nucleolin and YB-1 are required for JNK-mediated interleukin-2 mRNA stabilization during T-cell activation.
    Chen CY, Gherzi R, Andersen JS, Gaietta G, Jürchott K, Royer HD, Mann M, Karin M.
    Genes Dev; 2000 May 15; 14(10):1236-48. PubMed ID: 10817758
    [Abstract] [Full Text] [Related]

  • 18. The ETS transcription factor ESE-1 transforms MCF-12A human mammary epithelial cells via a novel cytoplasmic mechanism.
    Prescott JD, Koto KS, Singh M, Gutierrez-Hartmann A.
    Mol Cell Biol; 2004 Jun 15; 24(12):5548-64. PubMed ID: 15169914
    [Abstract] [Full Text] [Related]

  • 19. Y box-binding protein-1 binds preferentially to single-stranded nucleic acids and exhibits 3'-->5' exonuclease activity.
    Izumi H, Imamura T, Nagatani G, Ise T, Murakami T, Uramoto H, Torigoe T, Ishiguchi H, Yoshida Y, Nomoto M, Okamoto T, Uchiumi T, Kuwano M, Funa K, Kohno K.
    Nucleic Acids Res; 2001 Mar 01; 29(5):1200-7. PubMed ID: 11222770
    [Abstract] [Full Text] [Related]

  • 20. Phosphatidylinositol 3-kinase signaling mediates angiogenesis and expression of vascular endothelial growth factor in endothelial cells.
    Jiang BH, Zheng JZ, Aoki M, Vogt PK.
    Proc Natl Acad Sci U S A; 2000 Feb 15; 97(4):1749-53. PubMed ID: 10677529
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.